Introducing Libre Assist*
Progress is taking uncertainty off the menu.
Only FreeStyle Libre CGMs have Libre Assist*, which predicts food impact on your glucose† and gives feedback after you eat.
Try Libre Assist*, now available on the Libre app‡. Plus, your first sensor may be free♢! No credit card required, no strings attached.
Not actual patient data.
Not just another food logging app
With Libre Assist*, one photo helps you see your food’s potential glucose impact†. Just like that!
Snap.
Take a photo of your food.
Predict.
Libre Assist predicts how your food can impact glucose†.
Know.
See how food may affect your glucose†.
See how it works.
Learn more with these how-to videos.
How to use Libre Assist* in the Libre app‡
How to add food to Libre Assist* in the Libre app‡
See patterns and trends that show the impact of every meal, every workout, and every dose§.
Ask your doctor for a FreeStyle Libre 3 Plus sensor prescription today.
Not actual patient data.
With minute-to-minute readings, you can manage your diabetes with confidence||1 and lower your A1C¶2.
It’s painless3.
The small 15-day sensor is painless to apply and comfortable to wear3.
It’s convenient.
Without fingersticks#, you have less to manage and worry about. Glucose readings are sent to your smartphone‡.
It's easy to use||4.
You can monitor glucose discreetly, comfortably3, and conveniently anytime§ and anywhere**, just by checking your smartphone‡.
CGM = continuous glucose monitor(ing)
Download the latest version of the Libre app‡ now to use Libre Assist*.
Need a prescription for the FreeStyle Libre systems?
Talk to your healthcare provider today to see if the FreeStyle Libre systems are right for you.
More people pay $0–$20 for Libre than for Dexcom††5.
Libre has you covered through insurance or Abbott support‡‡§§5.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
Coverage and out-of-pocket costs may vary based on your individual insurance plan. Please contact your insurance provider directly to confirm your specific benefits and eligibility.
The FreeStyle Libre 3 system includes the Libre 3 Plus sensor, Libre 3 sensor, Libre 3 app, Libre app, and the Libre 3 reader.
The FreeStyle Libre 2 system includes the Libre 2 Plus sensor, Libre 2 sensor, Libre 2 app, Libre app, and the Libre 2 reader.
* Libre Assist is a feature within Libre app that uses generative artificial intelligence to provide information on how foods could impact your glucose levels. Generative artificial intelligence may not always be accurate, and it should not be used to make treatment decisions.
† Predicted glucose impact is based on user-provided food data and may differ from actual impact, which depends on sensor readings and factors like activity, stress, medication, and alcohol.
‡ The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
§ 60-minute warm-up required when starting the sensor.
|| Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and FreeStyle Libre 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
¶ Study was performed with the US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and FreeStyle Libre 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
# Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first twelve hours.
** Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
†† Based on pharmacy claims for the aggregate of patients covered by Commercial insurance, Managed Medicare, Managed Medicaid using the FreeStyle Libre personal CGM systems versus Dexcom CGM systems. Does not include fee-for-service Medicare or fee-for-service Medicaid. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
‡‡ Based on prescription claims for commercially insured and uninsured patients using the FreeStyle Libre personal CGM systems. May not include Medicare, Medicaid, and other federal or state healthcare program patients. The actual amount a patient pays may vary. FreeStyle Libre personal CGM systems require a prescription.
§§ Benefits apply to FreeStyle Libre personal CGM sensors and readers. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. Offer available to commercially insured and uninsured patients only. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. For Massachusetts residents, only those patients responsible for the full cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary.
♢ Eligible patients will receive one (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor for users with a compatible mobile phone operating system at $0 copay. The expiration date of the voucher is 60 days from the issue date. This program is available for patients with Type 1 diabetes or Type 2 diabetes or gestational diabetes. Patients ages 18 and older are eligible to sign up and receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor. Patients ages 2–17 are eligible to receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor through their parent or guardian. This offer is void where prohibited by law. Abbott may modify or rescind this offer at any time without notice. The discounts are not available to beneficiaries of Kaiser Permanente, Medicare, Medicaid or other federal or state healthcare programs, residents of Massachusetts, or US territories (other than Puerto Rico). The free (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor is provided as a sample and is limited to one sample per eligible person per product identification number. The FreeStyle Libre 2 Plus sensor or FreeStyle Libre 3 Plus sensor cannot be re-sold, traded nor submitted to any third-party payer for reimbursement and is not provided as any inducement for future purchases. The free sample card is not health insurance.
References: 1. Fokkert, Marion, et al. "Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4)." BMJ Open Diabetes Research and Care 7, no. 1 (2019): e000809. https://doi.org/10.1136/bmjdrc-2019-000809. 2. Wright, Eugene E., Jr., et al. “Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy.” Diabetes Spectrum 34, no. 2 (2021): 184–189. https://doi.org/10.2337/ds20-0069. 3. Alva, Shridhara, et al. "Accuracy of a 15-Day Factory-Calibrated Continuous Glucose Monitoring System with Improved Sensor Design." Journal of Diabetes Science and Technology (2025): 19322968251329364. https://doi.org/10.1177/19322968251329364. 4. Haak, Thomas, et al. "Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: A Multicenter, Open-Label Randomized Controlled Trial." Diabetes Therapy 8, no. 1 (2017): 55–73. https://doi.org/10.1007/s13300-016-0223-6. 5. Data on file. Abbott Diabetes Care, Inc.
ADC-119775 v1.0